FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024315965> ?p ?o ?g. }

• W2024315965 endingPage "29372" @default.
• W2024315965 startingPage "29362" @default.
• W2024315965 abstract "Neprilysin is one of the major amyloid-β peptide (Aβ)-degrading enzymes, the expression of which declines in the brain during aging. The decrease in neprilysin leads to a metabolic Aβ imbalance, which can induce the amyloidosis underlying Alzheimer disease. Pharmacological activation of neprilysin during aging therefore represents a potential strategy to prevent the development of Alzheimer disease. However, the regulatory mechanisms mediating neprilysin activity in the brain remain unclear. To address this issue, we screened for pharmacological regulators of neprilysin activity and found that the neurotrophic factors brain-derived neurotrophic factor, nerve growth factor, and neurotrophins 3 and 4 reduce cell surface neprilysin activity. This decrease was mediated by MEK/ERK signaling, which enhanced phosphorylation at serine 6 in the neprilysin intracellular domain (S6-NEP-ICD). Increased phosphorylation of S6-NEP-ICD in primary neurons reduced the levels of cell surface neprilysin and led to a subsequent increase in extracellular Aβ levels. Furthermore, a specific inhibitor of protein phosphatase-1a, tautomycetin, induced extensive phosphorylation of the S6-NEP-ICD, resulting in reduced cell surface neprilysin activity. In contrast, activation of protein phosphatase-1a increased cell surface neprilysin activity and lowered Aβ levels. Taken together, these results indicate that the phosphorylation status of S6-NEP-ICD influences the localization of neprilysin and affects extracellular Aβ levels. Therefore, maintaining S6-NEP-ICD in a dephosphorylated state, either by inhibition of protein kinases involved in its phosphorylation or by activation of phosphatases catalyzing its dephosphorylation, may represent a new approach to prevent reduction of cell surface neprilysin activity during aging and to maintain physiological levels of Aβ in the brain. Neprilysin is one of the major amyloid-β peptide (Aβ)-degrading enzymes, the expression of which declines in the brain during aging. The decrease in neprilysin leads to a metabolic Aβ imbalance, which can induce the amyloidosis underlying Alzheimer disease. Pharmacological activation of neprilysin during aging therefore represents a potential strategy to prevent the development of Alzheimer disease. However, the regulatory mechanisms mediating neprilysin activity in the brain remain unclear. To address this issue, we screened for pharmacological regulators of neprilysin activity and found that the neurotrophic factors brain-derived neurotrophic factor, nerve growth factor, and neurotrophins 3 and 4 reduce cell surface neprilysin activity. This decrease was mediated by MEK/ERK signaling, which enhanced phosphorylation at serine 6 in the neprilysin intracellular domain (S6-NEP-ICD). Increased phosphorylation of S6-NEP-ICD in primary neurons reduced the levels of cell surface neprilysin and led to a subsequent increase in extracellular Aβ levels. Furthermore, a specific inhibitor of protein phosphatase-1a, tautomycetin, induced extensive phosphorylation of the S6-NEP-ICD, resulting in reduced cell surface neprilysin activity. In contrast, activation of protein phosphatase-1a increased cell surface neprilysin activity and lowered Aβ levels. Taken together, these results indicate that the phosphorylation status of S6-NEP-ICD influences the localization of neprilysin and affects extracellular Aβ levels. Therefore, maintaining S6-NEP-ICD in a dephosphorylated state, either by inhibition of protein kinases involved in its phosphorylation or by activation of phosphatases catalyzing its dephosphorylation, may represent a new approach to prevent reduction of cell surface neprilysin activity during aging and to maintain physiological levels of Aβ in the brain." @default.
• W2024315965 created "2016-06-24" @default.
• W2024315965 creator A5007957055 @default.
• W2024315965 creator A5013301564 @default.
• W2024315965 creator A5018378610 @default.
• W2024315965 creator A5018503713 @default.
• W2024315965 creator A5023317571 @default.
• W2024315965 creator A5047809277 @default.
• W2024315965 creator A5061069554 @default.
• W2024315965 creator A5071488040 @default.
• W2024315965 date "2012-08-01" @default.
• W2024315965 modified "2023-09-26" @default.
• W2024315965 title "Cell Surface Expression of the Major Amyloid-β Peptide (Aβ)-degrading Enzyme, Neprilysin, Depends on Phosphorylation by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) and Dephosphorylation by Protein Phosphatase 1a" @default.
• W2024315965 cites W1597068157 @default.
• W2024315965 cites W1921573595 @default.
• W2024315965 cites W1958560494 @default.
• W2024315965 cites W1967237003 @default.
• W2024315965 cites W1968973248 @default.
• W2024315965 cites W1969592336 @default.
• W2024315965 cites W1971855284 @default.
• W2024315965 cites W1972172786 @default.
• W2024315965 cites W1972565866 @default.
• W2024315965 cites W1991991142 @default.
• W2024315965 cites W1998208719 @default.
• W2024315965 cites W2002202959 @default.
• W2024315965 cites W2010065903 @default.
• W2024315965 cites W2010773967 @default.
• W2024315965 cites W2020174502 @default.
• W2024315965 cites W2029532449 @default.
• W2024315965 cites W2030011352 @default.
• W2024315965 cites W2031231593 @default.
• W2024315965 cites W2034933548 @default.
• W2024315965 cites W2045734671 @default.
• W2024315965 cites W2046611084 @default.
• W2024315965 cites W2049000671 @default.
• W2024315965 cites W2052825194 @default.
• W2024315965 cites W2054082069 @default.
• W2024315965 cites W2059276703 @default.
• W2024315965 cites W2067894097 @default.
• W2024315965 cites W2071310220 @default.
• W2024315965 cites W2071610467 @default.
• W2024315965 cites W2076517751 @default.
• W2024315965 cites W2077527631 @default.
• W2024315965 cites W2080434394 @default.
• W2024315965 cites W2082452187 @default.
• W2024315965 cites W2087255758 @default.
• W2024315965 cites W2094958540 @default.
• W2024315965 cites W2095147724 @default.
• W2024315965 cites W2095727654 @default.
• W2024315965 cites W2096410114 @default.
• W2024315965 cites W2110795584 @default.
• W2024315965 cites W2112921676 @default.
• W2024315965 cites W2117983251 @default.
• W2024315965 cites W2125403403 @default.
• W2024315965 cites W2129337589 @default.
• W2024315965 cites W2153966730 @default.
• W2024315965 cites W2155863144 @default.
• W2024315965 cites W2386517867 @default.
• W2024315965 cites W2414929465 @default.
• W2024315965 doi "https://doi.org/10.1074/jbc.m112.340372" @default.
• W2024315965 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3436156" @default.
• W2024315965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22767595" @default.
• W2024315965 hasPublicationYear "2012" @default.
• W2024315965 type Work @default.
• W2024315965 sameAs 2024315965 @default.
• W2024315965 citedByCount "36" @default.
• W2024315965 countsByYear W20243159652013 @default.
• W2024315965 countsByYear W20243159652014 @default.
• W2024315965 countsByYear W20243159652015 @default.
• W2024315965 countsByYear W20243159652016 @default.
• W2024315965 countsByYear W20243159652017 @default.
• W2024315965 countsByYear W20243159652018 @default.
• W2024315965 countsByYear W20243159652019 @default.
• W2024315965 countsByYear W20243159652020 @default.
• W2024315965 countsByYear W20243159652021 @default.
• W2024315965 countsByYear W20243159652022 @default.
• W2024315965 countsByYear W20243159652023 @default.
• W2024315965 crossrefType "journal-article" @default.
• W2024315965 hasAuthorship W2024315965A5007957055 @default.
• W2024315965 hasAuthorship W2024315965A5013301564 @default.
• W2024315965 hasAuthorship W2024315965A5018378610 @default.
• W2024315965 hasAuthorship W2024315965A5018503713 @default.
• W2024315965 hasAuthorship W2024315965A5023317571 @default.
• W2024315965 hasAuthorship W2024315965A5047809277 @default.
• W2024315965 hasAuthorship W2024315965A5061069554 @default.
• W2024315965 hasAuthorship W2024315965A5071488040 @default.
• W2024315965 hasBestOaLocation W20243159651 @default.
• W2024315965 hasConcept C104826730 @default.
• W2024315965 hasConcept C11960822 @default.
• W2024315965 hasConcept C178666793 @default.
• W2024315965 hasConcept C181199279 @default.
• W2024315965 hasConcept C181912034 @default.
• W2024315965 hasConcept C184235292 @default.
• W2024315965 hasConcept C185592680 @default.
• W2024315965 hasConcept C55493867 @default.
• W2024315965 hasConcept C57074206 @default.
• W2024315965 hasConcept C86803240 @default.
• W2024315965 hasConcept C87325107 @default.

• next